Acute Upper GI Bleeding
Summary
Acute upper gastrointestinal bleeding is a medical emergency where bleeding occurs from the esophagus, stomach, or first part of the small intestine (duodenum). Picture your digestive tract as a series of pipes—when one springs a leak, blood can pour out rapidly, causing you to lose significant amounts of blood in a short time. Patients may vomit bright red blood (hematemesis) or pass black, tarry stools (melena) that look like tar and smell foul. This condition affects approximately 100-200 per 100,000 people annually and carries a mortality of 5-10% overall, rising to 30-40% in high-risk patients. The key to survival is rapid assessment, aggressive resuscitation, risk stratification using validated scores (like the Glasgow-Blatchford or Rockall scores), and urgent endoscopy to identify and treat the bleeding source. Most bleeds stop spontaneously, but those that don't require endoscopic, radiological, or surgical intervention.
Key Facts
- Definition: Bleeding from GI tract proximal to ligament of Treitz (duodenal-jejunal junction)
- Incidence: 100-200 per 100,000/year; ~50,000-100,000 hospitalizations/year (UK)
- Mortality: 5-10% overall; 30-40% in high-risk patients
- Time to endoscopy: Urgent (<24h) for high-risk, routine for low-risk
- Critical threshold: Hemoglobin drop >2g/dL or need for >2 units blood
- Key investigation: Urgent upper GI endoscopy (OGD)
- First-line treatment: IV access, fluid resuscitation, PPI (omeprazole 80mg IV), urgent endoscopy
Clinical Pearls
"Hematemesis = Upper GI bleed" — Vomiting blood always indicates upper GI bleeding (above ligament of Treitz). Bright red = active bleeding; coffee-ground = old blood. Melena (black stools) also indicates upper GI source (blood takes time to turn black as it passes through).
"Resuscitate first, investigate second" — Don't delay resuscitation for endoscopy. Get IV access, start fluids, check bloods, then scope. A dead patient can't be scoped.
"Rockall score predicts mortality, Glasgow-Blatchford predicts need for intervention" — Use Rockall for prognosis, GBS for deciding who needs urgent endoscopy and admission.
"Most peptic ulcers stop bleeding on their own" — 80% stop spontaneously. Endoscopy is for the 20% that don't—identify high-risk stigmata (active bleeding, visible vessel) and treat endoscopically.
Why This Matters Clinically
Acute upper GI bleeding is a common emergency with significant mortality if not managed promptly. Rapid blood loss can lead to hypovolaemic shock and death within hours. The key is early recognition, aggressive resuscitation, and risk stratification to identify those needing urgent endoscopy versus those who can be managed conservatively. Delayed recognition or inappropriate management (like giving NSAIDs to someone with a bleeding ulcer) can be fatal. Protocol-driven management focusing on resuscitation, risk assessment, and timely endoscopy can reduce mortality significantly.
Incidence & Prevalence
- Overall: 100-200 per 100,000/year
- UK: ~50,000-100,000 hospitalizations/year
- US: ~300,000 hospitalizations/year
- Trend: Decreasing (better H. pylori treatment, PPI use)
- Peak age: 60-70 years
Demographics
| Factor | Details |
|---|---|
| Age | Median age 65 years; rare <40 unless varices or Mallory-Weiss |
| Sex | Slight male predominance (55:45) |
| Ethnicity | Higher rates in certain populations (H. pylori prevalence) |
| Geography | Higher in areas with high H. pylori prevalence |
| Setting | Emergency departments, gastroenterology units |
Risk Factors
Non-Modifiable:
- Age >60 years
- Male sex
- Previous GI bleeding
Modifiable:
| Risk Factor | Relative Risk | Mechanism |
|---|---|---|
| NSAID use | 3-5x | Direct mucosal damage |
| Antiplatelet agents | 2-3x | Aspirin, clopidogrel |
| Anticoagulants | 2-4x | Warfarin, DOACs |
| H. pylori infection | 2-3x | Peptic ulcer disease |
| Alcohol excess | 2-3x | Gastritis, varices |
| Smoking | 1.5-2x | Peptic ulcer risk |
| Cirrhosis | 5-10x | Varices, portal hypertension |
Common Causes
| Cause | Frequency | Typical Patient |
|---|---|---|
| Peptic ulcer | 40-50% | Older, NSAID use, H. pylori |
| Varices | 10-15% | Cirrhosis, portal hypertension |
| Mallory-Weiss tear | 5-10% | Young, alcohol, vomiting |
| Gastritis/erosions | 10-15% | NSAID use, stress |
| Tumors | 2-5% | Older, weight loss |
| Dieulafoy lesion | 1-2% | Any age, recurrent bleeds |
| Aortoenteric fistula | Rare | Previous aortic surgery |
The Bleeding Cascade
Step 1: Underlying Pathology
- Peptic ulcer: Erosion through mucosa into blood vessel
- Varices: Portal hypertension → dilated veins → rupture
- Mallory-Weiss: Forceful vomiting → mucosal tear
- Gastritis: Inflammation → erosion → bleeding
Step 2: Vessel Exposure or Rupture
- Ulcer: Erodes into submucosal vessel (artery or vein)
- Varices: Thin-walled veins rupture under pressure
- Tear: Disrupts mucosal vessels
Step 3: Hemorrhage
- Arterial bleeding: Bright red, pulsatile, rapid
- Venous bleeding: Darker, slower
- Volume loss: Can be rapid (liters in minutes)
Step 4: Compensatory Mechanisms
- Sympathetic activation: Tachycardia, vasoconstriction
- Fluid shifts: Interstitial fluid moves to intravascular
- Result: Temporary maintenance of BP
Step 5: Decompensation
- If bleeding continues: Hypovolaemia → shock
- If stops: Spontaneous hemostasis (80% of cases)
Classification by Bleeding Stigmata (Endoscopic)
| Stigma | Risk of Rebleeding | Mortality | Endoscopic Treatment |
|---|---|---|---|
| Active spurting | 90%+ | High | Urgent endoscopic therapy |
| Visible vessel | 50% | Moderate | Endoscopic therapy |
| Adherent clot | 30% | Moderate | Consider endoscopic therapy |
| Flat spot | 10% | Low | Usually no treatment needed |
| Clean base | <5% | Low | No treatment needed |
Anatomical Considerations
Upper GI Tract Anatomy:
- Esophagus: 25cm long, can bleed from varices, tears, tumors
- Stomach: Large capacity, can hold significant blood
- Duodenum: First part (bulb) common site for ulcers
- Ligament of Treitz: Anatomical landmark (duodenal-jejunal junction)
Why Some Sites Bleed More:
- Gastric ulcers: Can erode into left gastric artery (large vessel)
- Duodenal ulcers: Can erode into gastroduodenal artery
- Varices: Thin walls, high pressure → rupture easily
Symptoms: The Patient's Story
Typical Presentation:
Presentation by Cause:
Peptic Ulcer:
Varices:
Mallory-Weiss Tear:
Signs: What You See
Vital Signs (Critical):
| Sign | Finding | Significance |
|---|---|---|
| Systolic BP | Low (<90) or normal | Hypotension = significant blood loss |
| Heart rate | Tachycardia (>100) | Compensatory response |
| Postural drop | BP drops >20mmHg on standing | Significant volume loss |
| Respiratory rate | May be increased | Compensatory or anxiety |
General Appearance:
Abdominal Examination:
Other Findings:
Red Flags
[!CAUTION] Red Flags — Immediate Escalation Required:
- Hematemesis (vomiting blood) — Confirms upper GI bleeding
- Melena (black, tarry stools) — Indicates upper GI source
- Hemodynamic instability (SBP <90 mmHg) — Significant blood loss
- Heart rate >100 bpm — Compensatory response to blood loss
- Altered mental status — Severe hypovolaemia or liver disease
- Syncope or near-syncope — Significant volume loss
- Active bleeding (ongoing hematemesis/melena) — Needs urgent endoscopy
- Postural hypotension — >20mmHg drop indicates volume depletion
Structured Approach: ABCDE
A - Airway
- Assessment: Usually patent
- Finding: May have blood in mouth if recent hematemesis
- Action: Clear airway if needed
B - Breathing
- Look: Respiratory rate, use of accessory muscles
- Listen: Usually normal (unless severe anemia)
- Measure: SpO2 (usually normal unless severe)
- Action: Oxygen if hypoxic or severe anemia
C - Circulation
- Look: Skin colour (pale), capillary refill
- Feel: Pulse (rate, volume), BP (lying and standing)
- Listen: Heart sounds (tachycardia)
- Measure: BP (both arms), HR, ECG
- Action: IV access x2 (large bore), fluid resuscitation
D - Disability
- Assessment: GCS, mental status
- Finding: May be confused if hypovolaemic or liver disease
- Action: Check glucose; consider if hypovolaemia causing confusion
E - Exposure
- Look: Full body examination, look for stigmata of liver disease
- Feel: Abdomen (tenderness, masses)
- Action: PR examination (check for melena)
Specific Examination Findings
Cardiovascular Assessment:
Postural Blood Pressure:
- Technique: Measure BP lying, then standing
- Finding: Drop >20mmHg systolic = significant volume loss
- Significance: Indicates need for fluid resuscitation
Pulse Assessment:
- Rate: Tachycardia (compensatory)
- Volume: Weak if significant blood loss
- Rhythm: Usually regular (may be irregular if AF)
Abdominal Examination:
- Inspection: Distension (if ascites), scars (previous surgery)
- Palpation: Epigastric tenderness (ulcer), hepatosplenomegaly (liver disease)
- Auscultation: Usually normal bowel sounds
Rectal Examination:
- Purpose: Confirm melena, assess for lower GI bleeding
- Finding: Black, tarry stool = melena (upper GI)
- Note: Always do PR in GI bleeding
Special Tests
| Test | Technique | Positive Finding | Clinical Use |
|---|---|---|---|
| Postural BP | Measure lying, then standing | Drop >20mmHg | Assesses volume status |
| Capillary refill | Press nail bed, release | >2 seconds | Poor perfusion |
| Shock index | HR/SBP | >1.0 | Indicates shock |
First-Line (Bedside) - Do Immediately
1. Full Blood Count
- Purpose: Assess blood loss
- Finding:
- Hemoglobin: May be normal initially (hemoconcentration), drops later
- MCV: Normal (acute blood loss)
- Platelets: May be low (liver disease, DIC)
- Action: Repeat in 4-6 hours (true Hb will show)
2. Coagulation Studies
- Purpose: Assess bleeding risk
- Finding:
- INR: May be elevated (liver disease, anticoagulants)
- PT/APTT: Prolonged if liver disease
- Action: Correct if possible (vitamin K, FFP)
3. Urea & Creatinine
- Purpose: Assess renal function
- Finding:
- Urea: Often elevated (blood breakdown in gut)
- Creatinine: Usually normal (unless CKD)
- Note: Urea:Creatinine ratio >100 suggests upper GI bleeding
4. Liver Function Tests
- Purpose: Assess for liver disease (varices risk)
- Finding: May be abnormal if cirrhosis
- Action: If abnormal, higher suspicion for varices
5. Group & Save / Crossmatch
- Purpose: Prepare for transfusion
- Action: Group & save if stable; crossmatch 4-6 units if unstable
Risk Stratification Scores
Glasgow-Blatchford Score (GBS):
| Parameter | Score |
|---|---|
| Hemoglobin (g/dL) | |
| Men: >12.0 = 0, 10-12 = 1, 8-10 = 3, <8 = 6 | |
| Women: >10 = 0, 8-10 = 1, <8 = 6 | |
| Urea (mmol/L) | |
| <6.5 = 0, 6.5-8 = 2, 8-10 = 3, 10-25 = 4, >25 = 6 | |
| Systolic BP | |
| >109 = 0, 100-109 = 1, <100 = 2 | |
| Heart rate | |
| <100 = 0, >100 = 1 | |
| Melena | 1 |
| Syncope | 2 |
| Liver disease | 2 |
| Heart failure | 2 |
Interpretation:
- GBS 0: Can be discharged (low risk)
- GBS 1-2: Consider discharge if stable
- GBS ≥3: Admit, consider urgent endoscopy
Rockall Score (Post-Endoscopy):
| Parameter | Score |
|---|---|
| Age | <60 = 0, 60-79 = 1, ≥80 = 2 |
| Shock | None = 0, Tachycardia = 1, Hypotension = 2 |
| Comorbidity | None = 0, Major = 2, Liver/kidney failure = 3 |
| Diagnosis | Mallory-Weiss = 0, All other = 1, Malignancy = 2 |
| Stigmata | None/clean base = 0, Blood/clot = 2, Spurting/vessel = 2 |
Interpretation:
- Rockall 0-2: Low risk (mortality <5%)
- Rockall 3-5: Moderate risk (mortality 10-15%)
- Rockall ≥6: High risk (mortality >30%)
Imaging
Upper GI Endoscopy (OGD) - Essential
| Finding | Significance | Treatment |
|---|---|---|
| Active bleeding | Spurting or oozing | Urgent endoscopic therapy |
| Visible vessel | Non-bleeding visible vessel | Endoscopic therapy |
| Adherent clot | Clot over ulcer | Consider endoscopic therapy |
| Flat spot | Pigmented spot | Usually no treatment |
| Clean base | Healed ulcer | No treatment needed |
Timing:
- Urgent (<24h): High-risk (GBS ≥3, active bleeding, unstable)
- Routine (24-48h): Low-risk, stable
CT Angiography (If Endoscopy Unavailable/Contraindicated):
- Indication: If cannot scope, or to locate source
- Finding: May show bleeding site, vascular abnormalities
- Note: Less sensitive than endoscopy
Diagnostic Criteria
Clinical Diagnosis:
- Hematemesis: Vomiting blood (confirms upper GI)
- Melena: Black, tarry stools (indicates upper GI)
- Hemodynamic instability: Suggests significant blood loss
Severity Assessment:
- Mild: Stable, GBS 0-2, no active bleeding
- Moderate: Some instability, GBS 3-5, may have active bleeding
- Severe: Unstable, GBS ≥6, active bleeding, high Rockall score
Management Algorithm
ACUTE UPPER GI BLEEDING PRESENTATION
(Hematemesis or melena)
↓
┌─────────────────────────────────────────────────┐
│ IMMEDIATE ASSESSMENT (<5 mins) │
│ • ABCDE approach │
│ • IV access (large bore x2) │
│ • Check FBC, U&Es, coagulation │
│ • Group & save / crossmatch │
│ • Calculate GBS score │
│ • Do NOT give oral intake │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ RESUSCITATION │
│ • Fluid resuscitation (crystalloid) │
│ • Blood transfusion if: │
│ - Hb <70 g/L (or <80 if cardiac disease) │
│ - Active bleeding │
│ - Hemodynamic instability │
│ • Correct coagulation if possible │
│ • PPI (omeprazole 80mg IV) │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ RISK STRATIFICATION │
├─────────────────────────────────────────────────┤
│ LOW RISK (GBS 0-2, stable) │
│ → Consider discharge if: │
│ - No further bleeding │
│ - Hb stable │
│ - Can follow up │
│ → Routine endoscopy (24-48h) │
│ │
│ MODERATE RISK (GBS 3-5) │
│ → Admit to ward │
│ → Urgent endoscopy (<24h) │
│ → Monitor closely │
│ │
│ HIGH RISK (GBS ≥6, unstable, active bleeding) │
│ → Admit to HDU/ICU │
│ → Urgent endoscopy (<12h, ideally <6h) │
│ → Prepare for endoscopic therapy │
│ → Consider interventional radiology/surgery │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ ENDOSCOPIC MANAGEMENT │
├─────────────────────────────────────────────────┤
│ ACTIVE BLEEDING or VISIBLE VESSEL │
│ → Endoscopic therapy: │
│ - Injection (adrenaline) │
│ - Thermal (cautery, APC) │
│ - Mechanical (clips) │
│ - Combination (usually best) │
│ │
│ ADHERENT CLOT │
│ → Consider removing clot │
│ → Treat underlying stigmata │
│ │
│ CLEAN BASE or FLAT SPOT │
│ → No endoscopic therapy needed │
│ → Medical management (PPI) │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ POST-ENDOSCOPY MANAGEMENT │
│ • High-dose PPI (omeprazole 80mg BD IV) │
│ • Monitor for rebleeding (24-48h) │
│ • Treat underlying cause: │
│ - H. pylori eradication (if ulcer) │
│ - Stop NSAIDs │
│ - Variceal banding/sclerotherapy │
│ • Consider repeat endoscopy if rebleeds │
└─────────────────────────────────────────────────┘
Acute/Emergency Management - The First Hour
Immediate Actions (Do Simultaneously):
-
Resuscitation
- IV access: Large bore cannulae x2 (16-18G)
- Fluids: Crystalloid (normal saline or Hartmann's)
- Blood: Transfuse if Hb <70 (or <80 if cardiac disease) or active bleeding
- Target: SBP >100, HR <100, adequate urine output
-
PPI (Proton Pump Inhibitor)
- Omeprazole: 80mg IV bolus, then 8mg/hour infusion
- Mechanism: Reduces acid → improves clot stability
- Evidence: Reduces rebleeding risk
-
Correct Coagulation
- If on warfarin: Consider reversal (vitamin K, FFP, prothrombin complex)
- If on DOACs: Consider reversal agents if available
- If liver disease: Vitamin K, FFP if bleeding
-
Nil by Mouth
- Why: Prepare for endoscopy
- Duration: Until endoscopy done
-
Risk Stratification
- Calculate GBS: Determines urgency
- Assess stability: BP, HR, ongoing bleeding
- Plan endoscopy: Urgent vs. routine
Medical Management
PPI Therapy:
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Omeprazole | 80mg bolus, then 8mg/hour | IV infusion | 72 hours | First-line |
| Pantoprazole | 80mg bolus, then 8mg/hour | IV infusion | 72 hours | Alternative |
Mechanism: Reduces gastric acid → improves clot stability → reduces rebleeding
Evidence: Reduces rebleeding risk by 50-70%
Transfusion Strategy:
| Indication | Transfusion Threshold | Target |
|---|---|---|
| Active bleeding | Transfuse immediately | Maintain Hb >80-100 |
| Stable, no cardiac disease | Hb <70 g/L | Target 70-90 |
| Stable, cardiac disease | Hb <80 g/L | Target 80-100 |
| Massive bleeding | Transfuse aggressively | Maintain circulation |
Note: Don't over-transfuse (increases portal pressure in varices)
Endoscopic Management
Indications for Endoscopic Therapy:
- Active bleeding: Spurting or oozing
- Visible vessel: Non-bleeding visible vessel
- Adherent clot: After clot removal, if stigmata underneath
Endoscopic Techniques:
| Technique | Mechanism | Success Rate | Notes |
|---|---|---|---|
| Injection (adrenaline) | Vasoconstriction, tamponade | 80-90% | Usually combined with other methods |
| Thermal (cautery) | Coagulates vessel | 85-95% | Bipolar, heater probe |
| Argon plasma coagulation | Coagulates surface | 80-90% | Good for superficial lesions |
| Mechanical (clips) | Clips vessel | 90-95% | Best for visible vessels |
| Combination | Multiple techniques | 95%+ | Usually best approach |
Variceal Bleeding:
| Technique | Indication | Success Rate |
|---|---|---|
| Band ligation | Esophageal varices | 90-95% |
| Sclerotherapy | If banding not possible | 85-90% |
| TIPS | Refractory bleeding | 90%+ |
Interventional Radiology
Angiography + Embolization:
- Indication: Endoscopy failed, or not possible
- Technique: Identify bleeding vessel, embolize
- Success rate: 70-90%
- Complications: Ischemia, rebleeding
TIPS (Transjugular Intrahepatic Portosystemic Shunt):
- Indication: Refractory variceal bleeding
- Mechanism: Reduces portal pressure
- Success rate: 90%+
- Complications: Hepatic encephalopathy, shunt stenosis
Surgical Management (Rare)
Indications:
- Failed endoscopic therapy: Continued bleeding despite endoscopy
- Massive bleeding: Cannot control endoscopically
- Perforation: Ulcer perforation
- Tumor: Bleeding tumor requiring resection
Procedures:
- Oversewing ulcer: Direct suture of bleeding vessel
- Gastrectomy: Partial or total (if extensive)
- Esophageal surgery: If varices or tumor
Disposition
Admit to ICU/HDU If:
- Hemodynamically unstable
- Active bleeding
- High Rockall score (≥6)
- Post-endoscopic therapy (monitor for rebleeding)
Admit to Ward If:
- Moderate risk (GBS 3-5)
- Stable after endoscopy
- Monitoring needed
Discharge Criteria:
- Low risk (GBS 0-2)
- No active bleeding for 24 hours
- Hb stable
- Can follow up (endoscopy arranged)
- Clear plan for H. pylori treatment if needed
Follow-Up:
- Endoscopy: If not done (routine, 24-48h)
- H. pylori test: If peptic ulcer (breath test, stool antigen)
- Medication review: Stop NSAIDs, optimize PPI
- Warning signs: Return if rebleeding
Immediate (Hours)
| Complication | Incidence | Presentation | Management |
|---|---|---|---|
| Hypovolaemic shock | 20-30% | Hypotension, tachycardia | Aggressive fluid/blood resuscitation |
| Rebleeding | 10-20% | Further hematemesis/melena | Repeat endoscopy, consider surgery |
| Aspiration | 5-10% | During vomiting | Suction, may need intubation |
| Myocardial ischemia | 5-10% | Chest pain, ECG changes | Treat shock, consider cardiac workup |
Rebleeding:
- Risk: Highest in first 48-72 hours
- Signs: Further hematemesis, melena, drop in Hb
- Management: Repeat endoscopy, may need surgery
- Prevention: Adequate endoscopic therapy, PPI
Early (Days)
1. Rebleeding (10-20%)
- Risk factors: High-risk stigmata, varices, large ulcers
- Management: Repeat endoscopy, consider surgery
- Prevention: Adequate initial therapy, PPI
2. Infection (5-10%)
- Aspiration pneumonia: From vomiting
- Line infections: From IV access
- Management: Antibiotics, aseptic technique
3. Acute Kidney Injury (10-20%)
- Cause: Hypovolaemia, contrast (if angiography)
- Management: Fluid resuscitation, monitor U&Es
- Prevention: Adequate resuscitation
Late (Weeks-Months)
1. Recurrent Bleeding (10-20%)
- Risk: Higher if underlying cause not addressed
- Management: Address cause (H. pylori, stop NSAIDs)
- Prevention: H. pylori eradication, PPI maintenance
2. Anemia (20-30%)
- Cause: Blood loss, may be chronic
- Management: Iron supplementation, may need transfusion
- Prevention: Adequate initial resuscitation
3. Underlying Condition Progression
- Ulcers: May recur if H. pylori not treated
- Varices: May rebleed if portal pressure not controlled
- Tumors: May progress if malignant
Natural History (Without Treatment)
Untreated Upper GI Bleeding:
- Mortality: 30-40% if massive, untreated
- Progression: Continued bleeding → hypovolaemic shock → death
- Time course: Death within hours if massive bleeding untreated
Outcomes with Treatment
| Variable | Outcome | Notes |
|---|---|---|
| In-hospital mortality | 5-10% | Overall; 30-40% in high-risk |
| 30-day mortality | 8-12% | Higher in elderly, comorbidities |
| Rebleeding rate | 10-20% | Highest in first 48-72h |
| Need for surgery | 5-10% | If endoscopic therapy fails |
| Long-term survival | 80-90% at 1 year | Depends on underlying cause |
Factors Affecting Outcomes:
Good Prognosis:
- Low Rockall score (0-2)
- Low GBS (0-2)
- Mallory-Weiss tear (usually self-limited)
- Young, healthy patient
- No comorbidities
- Successful endoscopic therapy
Poor Prognosis:
- High Rockall score (≥6)
- High GBS (≥6)
- Variceal bleeding (higher mortality)
- Malignancy (bleeding from tumor)
- Elderly, multiple comorbidities
- Failed endoscopic therapy
- Rebleeding
Prognostic Factors
| Factor | Impact on Prognosis | Evidence Level |
|---|---|---|
| Rockall score | Each point increases mortality 1.5x | High |
| Age | Each decade increases mortality 1.3x | High |
| Comorbidities | Each comorbidity increases mortality 1.5x | High |
| Variceal bleeding | 2x mortality vs. peptic ulcer | High |
| Rebleeding | 3x mortality if rebleeds | High |
| Endoscopic stigmata | Active bleeding = worse | High |
Key Guidelines
1. NICE Guidelines (2012) — UK guidelines for acute upper GI bleeding. National Institute for Health and Care Excellence
Key Recommendations:
- Risk stratify using GBS
- Urgent endoscopy for high-risk (GBS ≥3)
- PPI before and after endoscopy
- Endoscopic therapy for high-risk stigmata
- Evidence Level: 1A
2. International Consensus (2019) — International guidelines for non-variceal upper GI bleeding. Gastroenterology
Key Recommendations:
- Resuscitate before endoscopy
- Urgent endoscopy (<24h) for high-risk
- Combination endoscopic therapy
- High-dose PPI after endoscopy
- Evidence Level: 1A
3. Baveno VII Consensus (2022) — Guidelines for variceal bleeding. Journal of Hepatology
Key Recommendations:
- Antibiotic prophylaxis (reduces mortality)
- Band ligation for esophageal varices
- TIPS for refractory bleeding
- Evidence Level: 1A
Landmark Trials
Lau et al. (2000) — High-Dose PPI After Endoscopic Therapy
- Patients: 240 patients with bleeding peptic ulcers
- Intervention: High-dose omeprazole vs. placebo after endoscopic therapy
- Key Finding: Reduced rebleeding (6.7% vs. 22.5%)
- Clinical Impact: Established PPI after endoscopy
- PMID: 11058884
Sung et al. (2003) — Combination Endoscopic Therapy
- Patients: 156 patients with bleeding ulcers
- Intervention: Injection + thermal vs. injection alone
- Key Finding: Reduced rebleeding (8% vs. 20%)
- Clinical Impact: Established combination therapy as standard
- PMID: 12851875
Evidence Strength
| Intervention | Level | Key Evidence | Clinical Recommendation |
|---|---|---|---|
| PPI before endoscopy | 1B | Meta-analyses | Reduces need for endoscopic therapy |
| PPI after endoscopy | 1A | Multiple RCTs | Reduces rebleeding (Lau trial) |
| Endoscopic therapy | 1A | Multiple RCTs | For high-risk stigmata |
| Combination therapy | 1A | RCTs | Better than single method |
| Urgent endoscopy | 1B | Observational | For high-risk patients |
| Antibiotics (varices) | 1A | RCTs | Reduces mortality |
What is Acute Upper GI Bleeding?
Imagine your digestive system as a series of tubes. In acute upper GI bleeding, one of these tubes (your esophagus, stomach, or first part of your small intestine) starts bleeding. You might vomit blood (bright red if fresh, or like coffee grounds if it's been in your stomach) or pass black, tarry stools that look like tar and smell very bad. This happens when something damages the lining of your digestive tract—like an ulcer (a sore), swollen veins (varices), or a tear.
In simple terms: You're bleeding from your stomach or upper intestine, and blood is coming out either when you vomit or in your stools.
Why does it matter?
Acute upper GI bleeding can be serious because you can lose a lot of blood quickly. Your body needs blood to carry oxygen to your organs—without enough blood, your organs can start to fail. Even with the best treatment, about 5-10 out of 100 people don't survive, and this rises to 30-40 out of 100 in people who are already unwell. The good news? Most bleeds stop on their own, and with quick treatment (fluids, blood transfusion if needed, and a camera test to find and treat the cause), most people recover completely.
Think of it like this: It's like a pipe springing a leak—you need to find the leak and fix it before too much water (blood) is lost.
How is it treated?
1. Stopping the Bleeding: Doctors give you fluids and sometimes blood through a drip to replace what you've lost and keep your blood pressure up.
2. Finding the Cause: Doctors do a test called an endoscopy—a thin, flexible camera is passed through your mouth into your stomach to see where the bleeding is coming from. This is done under sedation so you don't feel it.
3. Treating the Bleeding: If the bleeding is still active or looks likely to bleed again, doctors can treat it through the camera:
- Injections: Medicine injected around the bleeding area
- Heat treatment: Cautery to seal the bleeding vessel
- Clips: Small clips to close the bleeding vessel
4. Treating the Underlying Cause:
- If it's an ulcer: Medicines to reduce acid, antibiotics if infection present
- If it's varices: Banding (tying off the swollen veins)
- If it's from medicines: Stop the offending medicine
The goal: Stop the bleeding, find and fix the cause, and prevent it happening again.
What to expect
In the Hospital:
- First few hours: Doctors will act quickly to stabilize you—fluids, blood if needed, and prepare for the camera test
- Day 1: You'll have the endoscopy (camera test) to find and treat the bleeding
- Days 2-3: You'll be monitored closely to make sure the bleeding doesn't start again
- Days 3-5: If everything is stable, you can usually go home
After Going Home:
- Medications: You'll need medicines (usually a PPI like omeprazole) to reduce stomach acid and help healing
- Diet: Usually a normal diet, but avoid alcohol and things that irritate your stomach
- Follow-up: Doctor visits and sometimes repeat camera tests to make sure everything is healed
- Lifestyle: Stop smoking, avoid NSAIDs (like ibuprofen), reduce alcohol if that was a factor
Recovery Time:
- In hospital: Usually 3-5 days
- At home: Most people feel back to normal within 1-2 weeks
- Full healing: Ulcers usually heal within 4-8 weeks with treatment
When to seek help
Call 999 (or your emergency number) immediately if:
- You vomit blood (bright red or coffee-ground)
- You pass black, tarry stools
- You feel very weak or faint
- You feel dizzy or lightheaded
- Your heart is racing
- You feel confused or "not yourself"
See your doctor urgently if:
- You've had upper GI bleeding before and feel unwell again
- You're taking blood thinners and notice dark stools
- You have ongoing stomach pain with other symptoms
- You're losing weight unexpectedly
Remember: If you vomit blood or pass black, tarry stools, don't wait—get emergency help immediately. This can be serious and needs prompt treatment.
Primary Guidelines
-
National Institute for Health and Care Excellence. Acute upper gastrointestinal bleeding: management. NICE guideline [CG141]. 2012. NICE
-
Laine L, Barkun AN, Saltzman JR, et al. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol. 2021;116(5):899-917. PMID: 33929377
-
de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-974. PMID: 35120736
Key Trials
-
Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343(5):310-316. PMID: 11058884
-
Sung JJ, Tsoi KK, Lai LH, et al. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut. 2007;56(10):1364-1373. PMID: 17566019
Further Resources
- NICE Guidelines: National Institute for Health and Care Excellence
- ACG Guidelines: American College of Gastroenterology
- Baveno Consensus: Journal of Hepatology
Conditions to Consider
Upper GI bleeding must be distinguished from other causes of blood in vomit or stool:
| Condition | Key Distinguishing Features | Investigation | Management Difference |
|---|---|---|---|
| Lower GI bleeding | Fresh red blood per rectum, no melena, unstable | Colonoscopy, CT angiogram | Different source, different endoscopy |
| Swallowed blood | Nosebleed, dental bleeding, no GI symptoms | History, ENT examination | No GI intervention needed |
| Hemoptysis | Coughing blood, frothy/pink, respiratory symptoms | CXR, bronchoscopy | Respiratory source, different management |
| Esophagitis | Heartburn, dysphagia, usually chronic | OGD shows inflammation | PPI, no endoscopic therapy usually |
| Gastric cancer | Weight loss, early satiety, chronic symptoms | OGD with biopsy | May need surgery/chemotherapy |
| Aortoenteric fistula | Previous aortic surgery, "herald bleed," massive bleeding | CT angiogram | Urgent vascular surgery |
| Portal hypertensive gastropathy | Cirrhosis, chronic anemia, endoscopy shows gastropathy | OGD | Medical management, TIPS if severe |
Clinical Differentiation
Upper vs. Lower GI Bleeding:
| Feature | Upper GI | Lower GI |
|---|---|---|
| Hematemesis | Yes | No |
| Melena | Yes (usually) | Rare (only if slow transit) |
| Hematochezia | Only if massive | Yes |
| Color | Black/coffee-ground | Bright red (usually) |
| Urea:Creatinine ratio | >100 | Normal |
| NG aspirate | Blood/coffee-ground | Clear |
Hematemesis vs. Hemoptysis:
| Feature | Hematemesis (GI) | Hemoptysis (Respiratory) |
|---|---|---|
| Mechanism | Vomiting | Coughing |
| Color | Dark red/brown | Bright red/pink |
| Consistency | Clots, food mixed | Frothy, bubbly |
| pH | Acidic (<4) | Alkaline (>7) |
| Symptoms | Nausea, abdominal pain | Cough, dyspnoea |
| Investigation | OGD | CXR, bronchoscopy |
Mimics & Pitfalls
1. Red Foods/Medications:
- Beetroot: Can cause red stools (not blood)
- Food coloring: Red jellies, drinks
- Medications: Iron (black stools), bismuth (black stools)
- Test: Stool occult blood test (negative if food)
2. Swallowed Blood:
- Sources: Nosebleed, dental bleeding, hemoptysis swallowed
- Clue: No GI symptoms, clear source of bleeding
- Management: Treat source, no GI investigation needed
3. Aortoenteric Fistula (Don't Miss!):
- Clue: Previous aortic graft surgery + "herald bleed" (small bleed before massive)
- Key: High suspicion if any GI bleed post-aortic surgery
- Investigation: Urgent CT angiogram
- Management: Urgent vascular surgery (mortality 50%+ if missed)
Primary Prevention (Before First Bleed)
Medication Review in High-Risk Patients:
| Medication | Alternative/Strategy | Rationale |
|---|---|---|
| NSAIDs | Paracetamol, COX-2 inhibitors (if needed) | Reduce ulcer risk |
| Aspirin | Use lowest effective dose (75mg) | Reduce bleeding risk |
| Anticoagulants | Regular review, monitor INR | Reduce over-anticoagulation |
| Dual antiplatelet | Consider PPI co-prescription | Reduce ulcer bleeding |
PPI Co-Prescription:
- Indication: If high-risk patient on NSAIDs/antiplatelet
- Drugs: Omeprazole 20mg daily, lansoprazole 30mg daily
- Evidence: Reduces ulcer bleeding by 60-70%
- Who: Age >65, previous ulcer, multiple risk factors
H. pylori Screening & Eradication:
- Who: Before starting long-term NSAIDs, previous ulcer history
- Test: Stool antigen, breath test, endoscopy biopsy
- Eradication: Clarithromycin triple therapy (reduces ulcer risk by 90%)
Secondary Prevention (After First Bleed)
Post-Bleeding Management:
| Intervention | Action | Duration | Evidence |
|---|---|---|---|
| PPI continuation | Omeprazole 20mg daily (or lansoprazole 30mg) | Long-term | 1A |
| H. pylori eradication | If positive, full eradication course | Once (confirm eradication) | 1A |
| Stop NSAIDs | Permanent if possible | Permanent | 1A |
| Aspirin review | Restart after 3-5 days if cardiovascular indication | As indicated | 1B |
| Anticoagulation review | Restart when safe (discuss with cardiology) | As indicated | 1B |
Aspirin Restarting:
- Cardiovascular indication (stent, MI, stroke): Restart after 3-5 days
- Primary prevention only: Consider stopping permanently
- Always: Use PPI co-prescription if restarting
Anticoagulation Restarting:
- Timing: Depends on bleeding risk vs. thrombosis risk
- High thrombosis risk (mechanical valve, AF with high CHADS2): Restart early (3-7 days)
- Low thrombosis risk: Can wait longer (1-2 weeks)
- Discuss: Cardiology/hematology input
Tertiary Prevention (Preventing Recurrence)
Lifestyle Modifications:
| Modification | Rationale | Evidence |
|---|---|---|
| Smoking cessation | Impairs ulcer healing, increases recurrence | 1A |
| Alcohol reduction | Reduces gastritis, varices risk | 1B |
| Avoid NSAIDs | Direct ulcer risk | 1A |
| Manage stress | Stress ulcers in high-risk patients | 1B |
Variceal Bleeding Prevention:
- Non-selective beta-blockers (propranolol, carvedilol): Reduce portal pressure
- Variceal banding: Elective banding for large varices
- TIPS: If refractory, repeated bleeding
Regular Follow-Up:
- Endoscopy: Repeat at 6-8 weeks to confirm healing (if ulcer)
- H. pylori: Confirm eradication (breath test, stool antigen)
- Medication review: Ensure PPI compliance, no NSAIDs
Elderly Patients (>75 Years)
Epidemiology:
- Incidence: 2-3x higher than younger patients
- Mortality: 15-20% (vs. 5-10% overall)
- Presentation: Often atypical (confusion, falls)
Management Considerations:
| Issue | Challenge | Approach |
|---|---|---|
| Polypharmacy | Multiple medications increasing bleeding risk | Review all medications, stop non-essential |
| Comorbidities | Cardiac, renal, increasing risk | Careful fluid balance, transfusion threshold |
| Frailty | Poor tolerance of procedures | Consider risks vs. benefits |
| Cognitive impairment | Difficulty with consent, compliance | Involve family, simplified regimens |
Treatment Adjustments:
- Lower transfusion threshold: Hb <80 (vs. <70) if cardiac disease
- Careful fluid balance: Higher risk of pulmonary oedema
- Consider goals of care: Early discussions if very frail
Prognosis:
- Worse than younger patients (mortality 2-3x higher)
- Higher risk of complications (aspiration, AKI)
Anticoagulated Patients
Warfarin:
| INR | Risk | Management |
|---|---|---|
| 1-1.5 | Low | No reversal needed, proceed with endoscopy |
| 1.5-2.5 | Moderate | Give vitamin K 2-5mg IV, consider FFP if urgent |
| >2.5 | High | Vitamin K 5-10mg IV + FFP or prothrombin complex concentrate (PCC) |
DOACs (Rivaroxaban, Apixaban, Dabigatran):
- Timing: Note last dose (reversal needed if <24h)
- Reversal agents:
- Dabigatran: Idarucizumab (Praxbind)
- Rivaroxaban/Apixaban: Andexanet alfa (if available)
- Alternative: Prothrombin complex concentrate (PCC) if specific reversal unavailable
Restarting Anticoagulation:
- High thrombosis risk: Restart after 3-7 days
- Low thrombosis risk: Can wait 1-2 weeks
- Always: Discuss with cardiology/hematology
Cirrhotic Patients (Variceal Bleeding)
Special Considerations:
| Issue | Management |
|---|---|
| Coagulopathy | FFP, platelets if active bleeding; vitamin K often ineffective |
| Thrombocytopenia | Transfuse if <50 and active bleeding |
| Encephalopathy | Higher risk during bleed; lactulose, rifaximin |
| Infection | Antibiotics prophylaxis (reduces mortality) |
| Renal dysfunction | Careful fluid balance, avoid nephrotoxins |
Variceal-Specific Management:
- Terlipressin: Reduces portal pressure, start immediately
- Antibiotics: Ciprofloxacin or ceftriaxone (reduces infection, improves survival)
- Band ligation: First-line endoscopic therapy
- TIPS: If refractory bleeding (within 72h if Child-Pugh B/C)
Prognosis:
- Worse than non-variceal bleeding (mortality 15-25%)
- Depends on Child-Pugh score (A = 10%, B = 20%, C = 40% mortality)
Chronic Kidney Disease Patients
Challenges:
| Issue | Impact | Management |
|---|---|---|
| Platelet dysfunction | Uremic platelets don't work well | Desmopressin (DDAVP) if active bleeding |
| Anemia | Baseline low Hb | Transfuse at higher threshold (Hb <80) |
| Fluid balance | Risk of overload | Careful fluid resuscitation, early dialysis if needed |
| Contrast exposure | Risk of contrast-induced AKI | Minimize contrast, hydration |
Management Adjustments:
- Transfusion threshold: Hb <80 (higher than standard)
- Fluid resuscitation: Cautious, monitor for overload
- Dialysis: Early if fluid overload despite diuretics
- Medications: Dose adjust for renal function
Pregnancy
Rare but Important:
| Cause | Management |
|---|---|
| Mallory-Weiss tear | Supportive, usually self-limited |
| Peptic ulcer | PPI safe in pregnancy, endoscopy if needed |
| Varices | Rare, manage as non-pregnant but consider fetal monitoring |
Medications:
- Safe: PPIs (omeprazole), sucralfate
- Avoid: Misoprostol (uterotonic), NSAIDs (late pregnancy)
- Endoscopy: Safe if needed, second trimester ideal
Multidisciplinary Care:
- Obstetrics involvement
- Fetal monitoring if >24 weeks viability
- Consider delivery if maternal instability threatens fetus
Post-Cardiac Surgery / Stent Patients
Dual Antiplatelet Therapy (DAPT):
- Recent stent (<6 months drug-eluting, <1 month bare-metal): Very high thrombosis risk
- Management:
- Stop aspirin/P2Y12 inhibitor temporarily (if massive bleeding)
- Restart as soon as possible (ideally <5 days)
- Discuss with cardiology urgently
Bridge Therapy:
- Not recommended: Heparin bridging increases bleeding risk
- Better: Restart oral antiplatelet as soon as endoscopy done
Last Reviewed: 2025-12-24 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment.